Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 487-492

  Nagaya, Noritoshi ^a,b   Uematsu, Masaaki ^a,b   Satoh, Toru ^a,b   Kyotani, Shingo ^a,b   Sakamaki, Fumio ^a,b   Nakanishi, Norifumi ^a,b   Yamagishi, Masakazu ^a,b   Kunieda, Takeyoshi ^a,b   Miyatake, Kunio ^a,b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ADOLESCENT; ADULT; AEROBIC METABOLISM; ARTICLE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART OUTPUT; HEMODYNAMICS; HUMAN; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL ANALYSIS; SURVIVAL RATE; URIC ACID BLOOD LEVEL;

EID: 0032814812     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.9812078     Document Type: Article

References (34)

1. 1. Leyva, F., S. D. Anker, J. W. Swan, I. F. Godsland, C. S. Wingrove, T.-P. Chua, J. C. Stevenson, and A. J. S. Coats. 1997. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur. Heart J. 18:858-865.
2. 2. Anker, S. D., F. Leyva, P. A. Poole-Wilson, W. J. Kox, J. C. Stevenson, and A. J. S. Coats. 1997. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 78:39-43.
3. 3. Hayabuchi, Y., S. Matsuoka, H. Akita, and Y. Kuroda. 1993. Hyperuricemia in cyanotic congenital heart disease. Eur. J. Pediatr. 152:873-876.
4. 4. Hasday, J. D., and C. M. Grum. 1987. Nocturnal increase of urinary uric acid:creatinine ratio: a biochemical correlate of sleep-associated hypoxemia. Am. Rev. Respir. Dis. 135:534-538.
5. 5. Braghiroli, A., C. Sacco, M. Erbetta, V. Ruga, and C. Donner. 1993. Overnight urinary acid:creatinine ratio for detection of sleep hypoxia: validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am. Rev. Respir. Dis. 148:173-178.
6. 6. Elsayed, N. M., J. M. Nakashima, and E. M. Postlethwait. 1993. Measurement of uric acid as a marker of oxygen tension in the lung. Arch. Biochem. Biophys. 302:228-232.
7. 7. Fox, A. C., G. E. Reed, H. Meilman, and B. B. Silk. 1979. Release of nucleosides from canine and human hearts as an index of prior ischemia. Am. J. Cardiol. 3:52-58.
8. 8. Mentzer, R. M., R. Rubio, and R. M. Berne. 1975. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am. J. Physiol. 229:1625-1631.
9. 9. Leyva, F., T. P. Chua, S. D. Anker, and A. J. Coats. 1998. Uric acid in chronic heart failure: a measure of anaerobic threshold. Metabolism 47:1156-1159.
10. 10. Anker, S. D., F. Leyva, P. A. Poole-Wilson, and A. J. S. Coats. 1998. Uric acid as independent predictor of impaired prognosis in patients with chronic heart failure (abstract). J. Am. Coll. Cardiol. 31:154A.
11. 11. Woolliscroft, J. O., H. Colfer, and I. H. Fox. 1982. Hyperuricemia in acute illness: a poor prognostic sign. Am. J. Med. 72:58-62.
12. 12. Hughes, J. D., and L. J. Rubin. 1986. Primary pulmonary hypertension: an analysis of 28 cases and a review of the literature. Medicine (Baltimore) 65:56-72.
13. 13. Rich, S., D. R. Dantzker, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P Fishman, R. M. Goldring, B. M. Groves, S. K. Koerner, P. C. Levy, L. M. Reid, C. E. Vreim, and G. W. Williams. 1987. Primary pulmonary hypertension: a national prospective study. Ann. Intern. Med. 107:216-223.
14. 14. Rich, S. 1988. Primary pulmonary hypertension. Prog. Cardiovasc. Dis. 31:205-238.
15. 15. Messerli, F., E. Frohlich, G. Dreslinski, D. Suarez, and G. Aristimuno. 1980. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann. Intern. Med. 93:817-821.
16. 16. Berkowitz, D. 1966. Blood lipid and uric acid interrelationships. J.A.M.A. 190:856-858.
17. 17. Friedman, E., and S. Wallace. 1964. Hypertriglyceridemia in gout. Circulation 29:508-511.
18. 18. Herman, J. B., and U. Gouldbourt. 1988. Uric acid and diabetes: observations in a population study. Lancet 2:240-243.
19. 19. Facchini, F., Y. D. Chen, C. B. Hollenbeck, and G. M. Reaven. 1991. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. J.A.M.A. 266:3008-3011.
20. 20. Antman, E. M., J. D. Marsh, L. H. Green, and W. Grossman. 1980. Blood oxygen measurements in the assessment of intracardiac left to right shunts: a critical appraisal of methodology. Am. J. Cardiol. 46:265-271.
21. 21. Domagk, G. F., and H. H. Schlicke. 1968. A colorimetric method using uricase and peroxidase for the determination of uric acid. Anal. Biochem. 22:219-224.
22. 22. Akizuki, S. 1982. Serum uric acid levels among thirty-four thousand people in Japan. Ann. Rheum. Dis. 41:272-274.
23. 23. Rehman, A., and S. A. Naqvi. 1980. Serum and urinary uric acid in relation to age and sex. J. Pak. Med. Assoc. 30:242-244.
24. 24. Nagaya, N., T. Satoh, M. Uematsu, Y. Okano, S. Kyotani, N. Nakanishi, and T. Kunieda. 1997. Shortening of doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction. Am. J. Cardiol. 79:1502-1506.
25. 25. Huizer, T., J. W. de Jong, J. A. Nelson, W. Czarnecki, P. W. Serruys, J. J. R. M. Bonnier, and R. Troquay. 1989. Urate production by human heart. J. Mol. Cell. Cardiol. 21:691-695.
26. 26. McCord, J. M. 1985. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:159-163.
27. 27. Ross, E. A., J. K. Perloff, G. M. Danovitch, J. S. Child, and M. M. Canobbio. 1986. Renal function and urate metabolism in late survivors with cyanotic congenital heart disease. Circulation 73:396-400.
28. 28. Darlington, L. G. 1986. Study to compare the relative hyperuricemic effects of frusemide and bumetanide. Adv. Exp. Med. Biol. 195(Pt. A): 333-339.
29. 29. D'Alonzo, G. E., R. J. Barst, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, J. T. Kernis, P. S. Levy, G. G. Pietra, L. M. Reid, J. T. Reeves, S. Rich, C. E. Vreim, G. W. Williams, and M. Wu. 1991. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann. Intern. Med. 115:343-349.
30. 30. Sandoval, J., O. Bauerle, A. Palomar, A. Gomez, M. L. Martinez-Guerra, M. Beltran, and M. L. Guerrero. 1994. Survival in primary pulmonary hypertension: validation of a prognostic equation. Circulation 89:1733-1744.
31. 31. Nagaya N., T. Nishikimi, Y. Okano, M. Uematsu, T. Satoh, S. Kyotani, S. Kuribayashi, S. Hamada, M. Kakishita, N. Nakanishi, M. Takamiya, T. Kunieda, H. Matsuo, and K. Kangawa. 1998. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J. Am. Coll. Cardiol. 31:202-208.
32. 32. Eysmann, S. B., H. I. Palevsky, N. Reichek, K. Hackney, and P. S. Douglas. 1989. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 80:353-360.
33. 33. Nagaya, N., Y. Goto, T. Satoh, M. Uematsu, S. Hamada, S. Kuribayashi, Y. Okano, S. Kyotani, N. Nakanishi, M. Takamiya, and Y. Ishida. 1998. Impaired regional fatty acid uptake closely correlates with systolic dysfunction in hypertrophied right ventricle. J. Nucl. Med. 39: 1676-1680.
34. 34. Boss, G. R., and J. E. Seegmiller. 1979. Hyperuricemia and gout: classification, complication and management. N. Engl. J. Med. 300:1459-1468.